During the quarter, the group made a regulatory provision of Rs 3,540 crore with regard to its investments in AIFs as per the Reserve Bank of India's (RBI) mandate
"By the end of September, we will have approximately Rs 6000 crore of cash in the balancesheet, which is much more than the LCR requirements"
The resolutions to renew the directorship of Ajay Piramal and Venu Srinvasan were also cleared by the shareholders
"We are on track to achieve the completion of demerger and separate listing of Piramal Pharma by the third quarter of the current financial year," PEL Chairperson Ajay Piramal said.
Some are 'Midnight's Children' whose pre-Independence businesses bloomed after 1947, some 'Licence Raj Warriors' who refused to let red-tapeism slow them down. A look at 25 towering business leaders
'We are on track to achieve retail loan disbursements of Rs 2,500 cr-3,500 cr in Q3FY23,' which is 5-7 times of pre-merger levels, says Piramal Group chairman Ajay Piramal
Pharmaceutical businesses that have a strong track record of quality compliance and can remain agile towards new regulatory requirements, will emerge stronger as the impact of the pandemic decreases, according to Piramal Enterprises Ltd Chairman Ajay G Piramal. Addressing shareholders in the company's annual report for 2021-22, Piramal said the company's pharma vertical is expected to have nearly 15 per cent CAGR revenue growth across businesses in the medium to long-term. "In the current circumstances, the pharmaceutical sector has emerged as an essential industry, with an ever-more critical role in today's evolving world," he wrote. Stating that the world's economy and infrastructure continue to be affected by significant supply chain disruptions and volatility in raw material costs, Piramal said safeguarding the supply chain is extremely critical and the company's teams have been pro-actively working towards diversifying vendor base and obtaining alternative suppliers to reduce .
The company has received 99 per cent of votes at the shareholders meeting held on Tuesday, PEL said in a statement
Piramal Group Chairman Ajay Piramal has received the prestigious Commander of the Order of the British Empire (CBE) award, a release said on Tuesday. Piramal has received the award for services to the UK-India trade relationship as India Co-Chair of the UK-India CEO Forum. Piramal said: "I am humbled and honoured to receive this honorary award from Her Majesty The Queen." As co-chair of India-UK CEO forum since 2016, the endeavour has been to help strengthen the strong bilateral relations between the two countries through greater economic co-operation, he added. "I'm delighted that Her Majesty The Queen has, in her Jubilee Year, approved Ajay Piramal an honorary CBE in recognition of the leading role Ajay has played in the UK-India relationship," Alan Gemmell, Her Majesty's Trade Commissioner for South Asia and British Deputy High Commissioner for Western India, said. The Commander of the Order of the British Empire (CBE) is awarded for having a prominent role at national level.
The committee in its meeting held on Wednesday approved the issuance of the NCDs on private placement basis, Piramal Enterprises said in a regulatory filing
The company had posted a net profit of Rs 799 crore for the same period last fiscal year
The company is focussing on growth and is scouting for more acquisitions
Completes acquisition; pays Rs 34,250 cr to creditors
In an interview, Piramal Group chairman said he would not hesitate to step down from Tata Sons board if there is a sense of conflict of interest after his acquisition of DHFL
DMart promoter Radhakishan Damani has reasons besides snob value for buying plush Malabar Hill property, say experts
The first Budget of this new decade reimagines India in the form of Aatmanirbhar Bharat like never before, Sunil Bharti Mittal, Chairman, Bharti Enterprises said
India's real estate market is grappling with a lingering lockdown that's slowed construction and sharply crimped new sales in an already struggling market.
Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd
The company said it was a strategic investment for PEL and it decided to sell as it saw good value for its shareholders. The sale value is roughly five times the annual sales of DRG
In visible signs of economic woes, the auto sector went through one of the longest sales slumps leading to nearly 3.5 lakh job losses.